Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke - TOAST

Description:

TOAST is a randomized, double-blind, placebo-controlled trial to test whether a low molecular heparinoid (ORG 10172) increases the likelihood of a favorable outcome at 3 months following acute ischemic stroke.